Tag Archives: from

HIV news from aidsmap.com

HIV news from aidsmap.com http://www.aidsmap.com/feeds/latest-hiv-news en <!– THEME DEBUG –> <!– THEME HOOK: ‘views_view_field’ –> <!– BEGIN OUTPUT from ‘core/themes/stable/templates/views/views-view-field.html.twig’ –> Chemsex is an emerging issue in the Middle East and eastern Europe <!– END OUTPUT from ‘core/themes/stable/templates/views/views-view-field.html.twig’ –> http://www.aidsmap.com/__%3C%21–%20THEME%20DEBUG%20–%3E_%3C%21–%20THEME%20HOOK%3A%20%27views_view_field%27%20–%3E_%3C%21–%20BEGIN%20OUTPUT%20from%20%27core/themes/stable/templates/views/views-view-field.html.twig%27%20–%3E_/news//news/dec-2019/chemsex-emerging-issue-middle-east-and-eastern-europe_%3C%21–%20END%20OUTPUT%20from%20%27core/themes/stable/templates/views/views-view-field.html.twig%27%20–%3E__ <!– THEME DEBUG –> <!– THEME HOOK: ‘views_view_field’ –> <!– BEGIN OUTPUT from ‘core/themes/stable/templates/views/views-view-field.html.twig’ –>… Read More »

Johnson & Johnson earnings beat expectations despite legal challenges from opioids and talc

Johnson & Johnson on Tuesday reported third-quarter earnings and revenue that beat expectations, boosted by higher sales of cancer and other prescription drugs, despite multimillion-dollar legal problems from talc and opioids. Here’s what the company reported compared with Wall Street estimates, based on a survey of analysts by Refinitiv: Adjusted earnings per share: $ 2.12… Read More »